Eric Kaldjian

SVP, Clinical Research at RareCyte

Eric earned his MD and trained in pathology at the University of Michigan. He was a research fellow at the National Cancer Institute and is certified by the American Board of Pathology. Before RareCyte he was the Medical Director of Companion Diagnostics at Ventana Medical Systems/Roche Tissue Diagnostics. Eric’s pharmaceutical experience has included discovery research, toxicology, and exploratory and late phase clinical development at Hoffmann-La Roche and Parke-Davis / Pfizer. He was a director of clinical genomics at Gene Logic and Chief Scientific Officer at Transgenomic. He has a degree in chemistry from Harvard and studied music at Trinity College, Cambridge, England.

Location

Ann Arbor, United States

Links


Org chart


Teams


Offices

This person is not in any offices


RareCyte

RareCyte is a company focused on characterizing and isolating rare cells from the blood.


Industries

Employees

11-50

Links